We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
JRC scientists propose most suitable analytical approaches that can serve as reference in the quantification of genetically modified food and feed ingredients and will impact harmonisation in official food control.
According to European legislation, the content of genetically modified organisms (GMOs) in a food or feed product has to be expressed as a relative quantity linked to the DNA of the ingredient (biological species).
For instance: GM maize is quantified relative to the total maize content of a product.
JRC scientists – in close collaboration with experts from international organisations - develop, evaluate and promote non-animal testing strategies based on in vitro methods to improve the regulatory assessment of chemicals which may cause developmental neurotoxicity (DNT) effects.
Currently there is only very limited information on potential developmental neurotoxicity (DNT) effects of the many thousands of chemicals that we come into contact with in our daily lives.
JRC scientists, in close collaboration with several European research organisations, have developed highly specific gold nanoparticles targeting malignant blood cancer cells. Such targeted nanocarriers enable the delivery of otherwise toxic drugs into the leukaemia cells and they can also serve a better diagnosis and treatment of leukemia.
JRC scientists contributed to a study paving the way to an easy production of biohybrid photonic nanostructures by simply feeding diatoms microalgae with tailored photoactive molecules.
Biotechnological processes harnessing living organisms' metabolism are low‐cost routes to nanostructured materials for applications in photonics, electronics, and nanomedicine. Some living organisms have optimised their ability to generate photoactive components – essential for their survival – with macro- to nanoscale structures.
The JRC, in close collaboration with the International Federation for Clinical Chemistry and Laboratory Medicine (IFCC), has embarked on standardisation activities related to the screening of colorectal cancer using Faecal Immunochemical Testing (FIT). The work aims at the comparability of testing results regardless of which tests are used in national screening programmes.
Colorectal cancer is the second most common cause of cancer death in Europe. However, when diagnosed at an early stage, the disease can be treated with a survival rate of around 90-95%.
The JRC released a new batch of a certified reference material (CRM) - ERM®-EF318k - consisting of gas oil that contains the Euromarker Solvent Yellow 124 to prevent taxation fraud. This CRM is highly requested, as it is essential for checking the proper use of energy fuel products within the European Union.
According to Council Directive 95/60/EC , all gas oil and kerosene products in Europe are taxed at a rate different from those used as propellants.